Otological aspects of <i>NLRP3</i>-related autoinflammatory disorder focusing on the responsiveness to anakinra

Abstract

We propose a constellation of biomarkers comprising NLRP3 genotypes, hearing status at diagnosis, and cochlear radiological findings as prognostic factors of hearing status after anakinra treatment and possibly as sensitive parameters for treatment dosage adjustment.